| Entry |
|
|---|
| Name |
Felbinac (JP16/USAN/INN);
Dolinac (TN);
Felbinac (TN)
|
|---|
| Formula |
C14H12O2
|
|---|
| Exact mass |
212.0837
|
|---|
| Mol weight |
212.2439
|
|---|
| Structure |
     |
|---|
| Activity |
Anti-inflammatory
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Target |
cyclooxygenase-1 (COX-1) inhibitor [HSA: 5742] [KO: K00509]; cyclooxygenase-2 (COX-2) inhibitor [HSA: 5743] [KO: K11987] |
|---|
| Pathway |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
264 Analgesics, anti-itchings, astringents, anti-inflammatory agents
2649 Others
D01675 Felbinac (JP16/USAN/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02AA Antiinflammatory preparations, non-steroids for topical use
M02AA08 Felbinac
D01675 Felbinac (JP16/USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases
cyclooxygenase-1 (COX-1) [HSA:5742] [KO:K00509]
Felbinac [ATC:M02AA08]
D01675 Felbinac (JP16/USAN/INN)
cyclooxygenase-2 (COX-2) [HSA:5743] [KO:K11987]
Felbinac [ATC:M02AA08]
D01675 Felbinac (JP16/USAN/INN)
 |
|---|
| Other DBs |
CAS: 5728-52-9 PubChem: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 16
1 C8x C 18.2700 -14.2800
2 C8x C 18.2700 -15.6800
3 C8x C 19.4824 -16.3800
4 C8x C 20.6949 -15.6800
5 C8y C 20.6949 -14.2800
6 C8x C 19.4824 -13.5800
7 C8y C 21.9260 -13.5690
8 C8x C 23.1312 -14.2647
9 C8x C 24.3435 -13.5646
10 C8y C 24.3435 -12.1646
11 C8x C 23.1383 -11.4689
12 C8x C 21.9259 -12.1690
13 C1b C 25.5614 -11.4612
14 C6a C 26.7734 -12.1607
15 O6a O 27.9523 -11.4798
16 O6a O 26.7740 -13.5796
BOND 17
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 7 12 1
14 10 13 1
15 13 14 1
16 14 15 1
17 14 16 2
|
|---|
